North America Pharmacogenomics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Pharmacogenomics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Pharmacogenomics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Pharmacogenomics Market Regional Analysis

6.2 North America Pharmacogenomics Market Revenue 2019-2028 (US$ Million)

6.3 North America Pharmacogenomics Market Forecast Analysis

7. North America Pharmacogenomics Market Analysis – by Technology

7.1 PCR

7.1.1 Overview
7.1.2 PCR: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Sequencing

7.2.1 Overview
7.2.2 Sequencing: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Microarray

7.3.1 Overview
7.3.2 Microarray: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Gel Electrophoresis

7.4.1 Overview
7.4.2 Gel Electrophoresis: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.5 Mass Spectrometry

7.5.1 Overview
7.5.2 Mass Spectrometry: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Pharmacogenomics Market Analysis – by Application

8.1 Drug Discovery

8.1.1 Overview
8.1.2 Drug Discovery: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Oncology

8.2.1 Overview
8.2.2 Oncology: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Neurology and Psychiatry

8.3.1 Overview
8.3.2 Neurology and Psychiatry: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.4 Pain Management

8.4.1 Overview
8.4.2 Pain Management: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.5 Cardiovascular Diseases

8.5.1 Overview
8.5.2 Cardiovascular Diseases: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Pharmacogenomics Market Analysis – by End User

9.1 Hospitals and Clinics

9.1.1 Overview
9.1.2 Hospitals and Clinics: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Biopharmaceutical Companies

9.2.1 Overview
9.2.2 Biopharmaceutical Companies: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 CROs and CDMOs

9.3.1 Overview
9.3.2 CROs and CDMOs: North America Pharmacogenomics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Pharmacogenomics Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Pharmacogenomics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Pharmacogenomics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Pharmacogenomics Market Breakdown, by Technology
10.2.1.1.2 US: North America Pharmacogenomics Market Breakdown, by Application
10.2.1.1.3 US: North America Pharmacogenomics Market Breakdown, by End User

10.2.1.2 Canada: North America Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Pharmacogenomics Market Breakdown, by Technology
10.2.1.2.2 Canada: North America Pharmacogenomics Market Breakdown, by Application
10.2.1.2.3 Canada: North America Pharmacogenomics Market Breakdown, by End User

10.2.1.3 Mexico : North America Pharmacogenomics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Pharmacogenomics Market Breakdown, by Technology
10.2.1.3.2 Mexico : North America Pharmacogenomics Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Pharmacogenomics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Oxford Nanopore Technologies

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Illumina, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 QIAGEN

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Myriad Genetics, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Admera Health

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Pharmacogenomics Market